A Phase II Study of Irinotecan, Oxaliplatin, Plus TS-1 in Untreated Metastatic Gastric Cancer

NCT00512681 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

44

Enrollment

OTHER_GOV

Sponsor class

Conditions

Stomach Neoplasms

Interventions

DRUG: Irinotecan, Oxaliplatin, TS-1

Sponsor

National Cancer Center, Korea